Baird Medical Investment Holdings Limited(BDMD)

Medical - Devices · Guangzhou, GD

$0.74-0.01 (-1.09%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Baird Medical Investment Holdings (BDMD) EV/FCF: History & Chart | TGMCharts

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T12:50:40.097Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:40.097Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 31,356,890
Total debt · period ending 2026-06-30: 14,223,073
Cash · period ending 2026-06-30: 289,083
TTM free cash flow · period ending 2025-12-31: N/A

FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BDMD EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

BDMD Competitors' EV/FCF Ratio

BDMD

Baird Medical Investment Holdings Limited

Current

Market Cap

$31.36M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs BDMD

Market Cap

$30.92M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs BDMD

Market Cap

$30.65M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BDMD

Market Cap

$32.31M

EV/FCF Ratio

N/A

TTM Avg

509.31x

3Y Avg

509.31x

5Y Avg

509.31x

BYSI

BeyondSpring Inc.

vs BDMD

Market Cap

$32.32M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs BDMD

Market Cap

$33.42M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BDMD

Market Cap

$33.52M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATYR

aTyr Pharma, Inc.

vs BDMD

Market Cap

$28.43M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs BDMD

Market Cap

$27.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs BDMD

Market Cap

$35.89M

EV/FCF Ratio

N/A

TTM Avg

17.34x

3Y Avg

44.12x

5Y Avg

46.63x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Baird Medical Investment Holdings Limited (BDMD)	$31.36M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$30.92M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$30.65M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.31M	N/A	509.31x	509.31x	509.31x
BeyondSpring Inc. (BYSI)vs ›	$32.32M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.42M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$33.52M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$28.43M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$27.31M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$35.89M	N/A	17.34x	44.12x	46.63x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

BDMD EV/FCF Ratio Metrics

BDMD Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics